Int. Immunopharmacol.

Extracorporeal human whole blood in motion, as a tool to predict first-infusion reactions and mechanism-of-action of immunotherapeutics.

Fletcher EAK, Eltahir M, Lindqvist F, ..., Leja-Jarblad J, Mangsbo SM

Int. Immunopharmacol. 54 (-) 1-11 [2018-01-00; online 2017-10-27]

Affiliated researcher

CCL2 mediates anti-fibrotic effects in human fibroblasts independently of CCR2.

Kalderén C, Stadler C, Forsgren M, ..., Sydow-Bäckman M, Svensson Gelius S

Int. Immunopharmacol. 20 (1) 66-73 [2014-05-00; online 2014-02-26]

Affiliated researcher